106 results about "Therapeutic ultrasound" patented technology

An ultrasound system has a catheter including an elongate flexible catheter body having at least one lumen extending longitudinally therethrough. The catheter further includes an ultrasound transmission member extending longitudinally through the lumen of the catheter body, the ultrasound transmission member having a proximal end connectable to a separate ultrasound generating device and a distal end coupled to the distal end of the catheter body. The distal end of the catheter body is deflectable. The ultrasound system also includes a sonic connector that connects the ultrasound transmission member to an ultrasound transducer. The ultrasound system also provides a method for reverse irrigation and removal of particles.

A transducer device for therapeutic applications is disclosed. The transducer device may include a mounting body configured for mounting the device to a finger of an operator of the device. The transducer device may also include a transducer housing connected to the mounting body that defines a receiving portion. The transducer device may further include a transducer element disposed in the receiving portion that is configured for connection to an energy supply and configured to transmit energy from an emitting surface. The transducer device may further include a gas reservoir disposed between the transducer element and the mounting body that is configured to prevent transmission of energy. The transducer device may further include a membrane connected to the transducer housing and disposed adjacent the emitting surface of the transducer element, and a cooling lumen for providing fluid to the membrane. A method of applying therapeutic ultrasound is also disclosed.

Methods and apparatus for the remote coagulation of blood using high-intensity focused ultrasound (HIFU) are provided. A remote hemostasis method comprises identifying a site of internal bleeding and focusing therapeutic ultrasound energy on the site, the energy being focused through an intervening tissue. An apparatus for producing remote hemostasis comprises a focused therapeutic ultrasound radiating surface and a sensor for identifying a site of internal bleeding, with a registration means coupled to the radiating surface and the sensor to bring a focal target and the bleeding site into alignment. The sensor generally comprises a Doppler imaging display. Hemostasis enhancing agents may be introduced to the site for actuation by the ultrasound energy.

Methods and systems for noninvasive mastopexy through deep tissue tightening with ultrasound are provided. An exemplary method and system comprise a therapeutic ultrasound system configured for providing ultrasound treatment to a deep tissue region, such as a region comprising muscular fascia and ligaments. In accordance with various exemplary embodiments, a therapeutic ultrasound system can be configured to achieve depth from 1 mm to 4 cm with a conformal selective deposition of ultrasound energy without damaging an intervening tissue in the range of frequencies from 1 to 15 MHz. In addition, a therapeutic ultrasound can also be configured in combination with ultrasound imaging or imaging / monitoring capabilities, either separately configured with imaging, therapy and monitoring systems or any level of integration thereof.

Methods and systems for treating stretch marks through deep tissue tightening with ultrasound are provided. An exemplary method and system comprise a therapeutic ultrasound system configured for providing ultrasound treatment to a shallow tissue region, such as a region comprising an epidermis, a dermis and a deep dermis. In accordance with various exemplary embodiments, a therapeutic ultrasound system can be configured to achieve depth from 0 mm to 1 cm with a conformal selective deposition of ultrasound energy without damaging an intervening tissue in the range of frequencies from 2 to 50 MHz. In addition, a therapeutic ultrasound can also be configured in combination with ultrasound imaging or imaging / monitoring capabilities, either separately configured with imaging, therapy and monitoring systems or any level of integration thereof.

A method of treating a perforator vein comprises applying ultrasound to the perforator vein and occluding the perforator vein with the ultrasound. An apparatus for treating blood vessels comprises an ultrasound emitter, wherein the ultrasound emitter is configured to emit ultrasound at multiple therapeutic ultrasound frequencies during a treatment cycle. The apparatus further comprises an acoustic coupler in sonic communication with the emitter, wherein the acoustic coupler has an acoustic coupling surface configured to contact a patient and facilitate delivery of ultrasound to the patient and wherein the acoustic coupler provides a conduction path for ultrasound from the emitter to the acoustic coupling surface. The apparatus further comprises an acoustic coupler containing a displaceable acoustic coupling material. The apparatus further comprises an acoustic coupler configured to vary the length of the conduction path in accordance with variation in the thickness of the acoustic coupling material disposed between the emitter and the acoustic coupling surface.

Methods and systems for noninvasive mastopexy through deep tissue tightening with ultrasound are provided. An exemplary method and system comprise a therapeutic ultrasound system configured for providing ultrasound treatment to a deep tissue region, such as a region comprising muscular fascia and ligaments. In accordance with various exemplary embodiments, a therapeutic ultrasound system can be configured to achieve depth from 1 mm to 4 cm with a conformal selective deposition of ultrasound energy without damaging an intervening tissue in the range of frequencies from 1 to 15 MHz. In addition, a therapeutic ultrasound can also be configured in combination with ultrasound imaging or imaging / monitoring capabilities, either separately configured with imaging, therapy and monitoring systems or any level of integration thereof.

A disposable transducer seal designed to seal an open aperture of a transducer housing for a therapeutic ultrasound procedure. The seal has a membrane, a retainer and a mating device for locking in place with the transducer housing. The membrane is essentially transparent to ultrasound energy while being stretched taunt about the retainer.

Various embodiments provide systems and methods of treating damaged cartilage injuries to joints and connective tissue. Methods and systems useful for permanent relief of pain in joints are also provided herein. Various embodiments provide for combining therapeutic ultrasound energy directed to a joint with a medicant injected into the joint.

The invention discloses a system for delivering acoustic energy to a subject in connection with high intensity focused ultrasound (HIFU) systems. In an embodiment, the system comprises an optionally disposable waveguide-attached ablation applicator coupled with an optionally re-usable waveguide, and an optional acoustic power source. The systems may comprise acoustic energy exit port intensity control, waveguide heat-sinking, and transducer operational adjustments that accommodate waveguide effects on the traversing acoustic power.

Non-invasive inactivation of nerve conduction in a treatment region of a mammalian subject as, for example, a region encompassing a renal artery. A therapeutic ultrasound transducer (31) is engaged with the body of the subject outside of the treatment region, preferably with the skin of the subject in proximity to the treatment region (10). The transducer is actuated to transmit therapeutically effective softly focused ultrasound energy at a level which brings tissues throughout a relatively large impact volume (22), desirably 1 cm3 or larger, to a temperature sufficient to inactivate conduction nerves but insufficient to cause rapid necrosis. The impact volume can be aligned with the treatment region using imaging techniques. The treatment can be applied without imaging or precisely locating individual nerves, and can be used, for example, to inactive renal nerves in treatment of hypertension.

The percutaneous probe, made in MRI-compatible materials, comprises: a body percutaneously inserted into the tissue of a patient's body organ (8) having a region (10) to be analyzed, treated and monitored during a single medical procedure; at least one information collection sensing device (30,33,34); treatment application transducers (30) 360° disposed to emit focused or defocused therapeutic ultra-sound waves. The computerized system comprises a parametrizable command device (50) adapted to simulate then command a generation of the therapeutic ultra-sound waves, and to monitor the treatment by thermal MRI images.

A method, using high intensity ultrasound, which may also be combined with a chemotherapy agent, that can result the direct destruction of tumor cells and in the reduction or elimination of local reoccurrence of cancer after removal of cancerous tissue, such as a surgical breast lumpectomy or surgical excision of a brain tumor. The method comprises either (1) the treatment of the tumor directly with High Intensity Focused Ultrasound, or (2) the treatment of the margins of the tissue surrounding the surgical cavity or void with ablative continuous wave high intensity ultrasound and a combination of a locally delivered chemotherapy agent and high intensity ultrasound, termed sonoporation. The present invention permits both the direct destruction (ablation) of tumor tissue as well as the destruction of tissue around the surgical margin and may include the enhanced local cellular uptake of locally injected chemotherapeutic drugs, all of which can be accomplished by a therapeutic ultrasound device used during surgery.

An ultrasound probe comprises therapeutic transducers which include a plurality of arrayed first transducer elements and emit therapeutic ultrasounds to a subject, and diagnostic transducers which include a plurality of arrayed second transducer elements and emit diagnostic ultrasounds to the subject and receive the diagnostic ultrasounds, wherein the therapeutic transducers are stacked over the diagnostic transducers.

An ultrasound system has a catheter including an elongate flexible catheter body having at least one lumen extending longitudinally therethrough. An ultrasound transmission wire extends longitudinally through the lumen of the catheter body, and has a proximal region, a distal region, and an intermediate region between the proximal region and the distal region. A sonic connector is connected to the proximal region of the ultrasound transmission wire, and a distal head is positioned at the distal end of the catheter body and coupled to the distal region of the ultrasound transmission wire. The proximal region of the ultrasound transmission wire has a larger diameter than the intermediate region, the intermediate region is continuously tapered with a progressively decreasing diameter from its proximal end to its distal end, and the distal region has a greater diameter than the distal end of the intermediate region.

Methods and systems for treating stretch marks through deep tissue tightening with ultrasound are provided. An exemplary method and system comprise a therapeutic ultrasound system configured for providing ultrasound treatment to a shallow tissue region, such as a region comprising an epidermis, a dermis and a deep dermis. In accordance with various exemplary embodiments, a therapeutic ultrasound system can be configured to achieve depth from 0 mm to 1 cm with a conformal selective deposition of ultrasound energy without damaging an intervening tissue in the range of frequencies from 2 to 50 MHz. In addition, a therapeutic ultrasound can also be configured in combination with ultrasound imaging or imaging / monitoring capabilities, either separately configured with imaging, therapy and monitoring systems or any level of integration thereof.

Novel targeted compositions which may be used for diagnostic and therapeutic use. The compositions can be used in conjunction with diagnostic imaging, such as ultrasound, as well as therapeutic applications, such as therapeutic ultrasound.

The described embodiments relate to methods, systems and uses for therapeutic ultrasound, and in particular, to methods, systems and uses for therapeutic ultrasound for treating or alleviating eye conditions. The described embodiments relate to methods, systems and uses that involve an ultrasound device configured for treatment of an eye condition, where the device comprises at least one ultrasound transducer for coupling to at least a portion of an eyelid to supply ultrasound waves to an area proximate to the portion of the eyelid according to treatment parameters, wherein the treatment parameters comprise a treatment frequency and a treatment period.

A protective thin film adhesive dressing 10 is disclosed for use during diagnostic ultrasound exams and therapeutic ultrasound treatments. Thin film dressing 10 accommodates and covers various shaped transducers 22 and provides a sterile contact surface between a transducer's acoustic window 24 and a body 34, human or animal. Thin film dressing 10 is transparent, ultra light weight and does not change the shape or dimensions of an ultrasound probe 22 during use. Ultrasound wave freely traverse thin film dressing 10 without have a contact media such a gel 20 between acoustic window 24 and the inner surface of thin film dressing 10.

An ultrasound system has a catheter including an elongate flexible catheter body having at least one lumen extending longitudinally therethrough. An ultrasound transmission wire extends longitudinally through the lumen of the catheter body, and has a proximal region, a distal region, and an intermediate region between the proximal region and the distal region. A sonic connector is connected to the proximal region of the ultrasound transmission wire, and a distal head is positioned at the distal end of the catheter body and coupled to the distal region of the ultrasound transmission wire. The proximal region of the ultrasound transmission wire has a larger diameter than the intermediate region, the intermediate region is continuously tapered with a progressively decreasing diameter from its proximal end to its distal end, and the distal region has a greater diameter than the distal end of the intermediate region.

Therapeutic ultrasound devices and methods are provided. The device (10) generally includes a substrate, for example, a flexible substrate (14), and multiple, individual transducer elements (16a, 16b, 16c) disposed on a face (18) of the substrate (14). The device may be provided as a part of an ultrasound system for that includes a generator unit and a controller including drive electronics. The device and method is especially useful for the treatment of ischemia and hypoxia using ultrasound levels that are generally no greater than those used for diagnostic purposes.

Methods and devices are described which allow sound waves to be safely be applied to the eyelid of an eye of a patient or through the eyelid to other structures in the eye or to or through structures in the facial region to effect changes to one or more structures in and around the eye or directly through the cornea or sclera to regions of the eye to treat one or more diseases of the eye.

A control apparatus (106) for controlling a therapeutic apparatus (100), wherein the control apparatus comprises: —an ultrasound control interface (110) for controlling a therapeutic ultrasound system (102), —a magnetic resonance control interface (112) for controlling a magnetic resonance apparatus (104) adapted for acquiring magnetic resonance imaging data from a subject and for acquiring magnetic resonance spectroscopy data from a subject (244), —an image processing module (124, 126, 128) for generating at least one magnetic resonance imaging image (500) from the magnetic resonance imaging data and for generating at least one magnetic resonance spectroscopy map (502, 514, 516, 518, 520) from the magnetic resonance spectroscopy data, —a planning module (120) adapted for receiving the magnetic resonance imaging image and the magnetic resonance spectroscopy map and for outputting planning data (732), —a control module (122) adapted for controlling the therapeutic ultrasound system using the ultrasound control apparatus using the planning data, wherein the control module is further adapted for controlling the acquisition of the acquiring magnetic resonance imaging data and magnetic resonance spectroscopy data using the magnetic resonance control interface.

Novel targeted compositions which may be used for diagnostic and therapeutic use. The compositions may comprise lipid, protein or polymer gas-filled vesicles which further comprise novel compounds of the general formula L-P-T, wherein L comprises a hydrophobic compound, P comprises a hydrophilic polymer, and T comprises a targeting ligand which targets tissues, cells or receptors, including myocardial cells, endothelial cells, epithelial cells, tumor cells and the glycoprotein GPIIbIIIa receptor. The compositions can be used in conjunction with diagnostic imaging, such as ultrasound, as well as therapeutic applications, such as therapeutic ultrasound.

Ultrasonic treatment equipment is provided which repeats therapeutic ultrasound exposure while measuring a degree of vessel constriction on a therapeutic ultrasound exposure basis. This equipment includes: a therapeutic ultrasonic transducer 2 which exposes a blood vessel of an affected part to a focused therapeutic ultrasonic wave for a specified period of exposure time; an imaging ultrasonic probe 3 which images an ultrasound tomographic image of the affected part; a display unit 24 which displays the ultrasound tomographic image; means 21 for detecting a blood flow signal from a signal received by the imaging ultrasonic probe and determining the blood flow velocity of the blood vessels of the affected part; means 21 for calculating a rate of change in blood flow velocity during the exposure to the therapeutic ultrasonic wave or before and after the exposure to the therapeutic ultrasonic wave; and means 23 for controlling exposure conditions of the therapeutic ultrasonic wave on the basis of the rate of change in blood flow velocity, and thereby controlling the therapeutic ultrasonic transducer.

An accommodative standoff holder 10 which can be used for both diagnostic and therapeutic ultrasound is disclosed. The described standoff holder 10 has the ability to be mounted on and utilized with transducers 20 of different sizes and shapes. The standoff holder 10 includes a gel insert 26 which is removable and self adjusting assuring contact between a human body, an animal, or other object and the acoustic window 22 of a transducer 22. Further, a gel insert 26 and method of making gel inserts 26 from a gel pad 24 is described.